234 related articles for article (PubMed ID: 33324671)
21. Evaluation of the relationship between serum ghrelin levels and cancer cachexia in patients with locally advanced nonsmall-cell lung cancer treated with chemoradiotherapy.
Uysal P; Afsar CU; Sozer V; Inanc B; Agaoglu F; Gural Z; Fazlıoglu NY; Cuhadaroglu C; Uzun H
J Cancer Res Ther; 2020; 16(4):855-859. PubMed ID: 32930130
[TBL] [Abstract][Full Text] [Related]
22. Locally advanced hypopharyngeal and laryngeal cancer: Influence of HPV status.
Bates JE; Morris CG; Hitchcock KE; Dziegielewski PT; Mendenhall WM; Amdur RJ
Radiother Oncol; 2019 Nov; 140():6-9. PubMed ID: 31174105
[TBL] [Abstract][Full Text] [Related]
23. Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94).
Ghadjar P; Pöttgen C; Joos D; Hayoz S; Baumann M; Bodis S; Budach W; Studer G; Stromberger C; Zimmermann F; Kaul D; Plasswilm L; Olze H; Bernier J; Wust P; Aebersold DM; Budach V
Strahlenther Onkol; 2016 Aug; 192(8):552-60. PubMed ID: 27323753
[TBL] [Abstract][Full Text] [Related]
24. Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer.
Lin YC; Ling HH; Chang PH; Pan YP; Wang CH; Chou WC; Chen FP; Yeh KY
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578846
[TBL] [Abstract][Full Text] [Related]
25. Impact of Induction Chemotherapy in Locally Advanced HPV-negative Oropharyngeal Cancer. A Propensity Score-matched analysis.
DE Felice F; Abate G; Galdieri A; Bulzonetti N; Musio D; Tombolini V
Anticancer Res; 2016 Dec; 36(12):6667-6672. PubMed ID: 27920000
[TBL] [Abstract][Full Text] [Related]
26. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Haddad RI; Massarelli E; Lee JJ; Lin HY; Hutcheson K; Lewis J; Garden AS; Blumenschein GR; William WN; Pharaon RR; Tishler RB; Glisson BS; Pickering C; Gold KA; Johnson FM; Rabinowits G; Ginsberg LE; Williams MD; Myers J; Kies MS; Papadimitrakopoulou V
Ann Oncol; 2019 Mar; 30(3):471-477. PubMed ID: 30596812
[TBL] [Abstract][Full Text] [Related]
27. Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy.
Chargi N; Wegner I; Markazi N; Smid E; de Jong P; Devriese L; de Bree R
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919607
[TBL] [Abstract][Full Text] [Related]
28. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer.
Bruixola G; Caballero J; Papaccio F; Petrillo A; Iranzo A; Civera M; Moriana M; Bosch N; Maroñas M; González I; Pastor M; Cervantes A
ESMO Open; 2018; 3(6):e000425. PubMed ID: 30426973
[TBL] [Abstract][Full Text] [Related]
30. Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan.
Kapała A; Surwiłło-Snarska A; Jodkiewicz M; Kawecki A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064057
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
Ou D; Garberis I; Adam J; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
Radiother Oncol; 2018 Jan; 126(1):116-124. PubMed ID: 29079308
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy in locally advanced head and neck squamous cell carcinoma.
Gyawali B; Shimokata T; Honda K; Ando Y
Cancer Treat Rev; 2016 Mar; 44():10-6. PubMed ID: 26924194
[TBL] [Abstract][Full Text] [Related]
33. Tooth extractions prior to chemoradiation or bioradiation are associated with weight loss during treatment for locally advanced oropharyngeal cancer.
Buurman DJM; Willemsen ACH; Speksnijder CM; Baijens LWJ; Hoeben A; Hoebers FJP; Kessler P; Schols AMWJ
Support Care Cancer; 2022 Jun; 30(6):5329-5338. PubMed ID: 35278135
[TBL] [Abstract][Full Text] [Related]
34. Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.
Nagasaka M; Zaki M; Issa M; Kim H; Abrams J; Sukari A
Laryngoscope; 2017 Oct; 127(10):2260-2264. PubMed ID: 28271529
[TBL] [Abstract][Full Text] [Related]
35. Influence of fat-free mass index on the survival of patients with head and neck cancer.
Lapornik N; Avramovič Brumen B; Plavc G; Strojan P; Rotovnik Kozjek N
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1909-1917. PubMed ID: 36437380
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study.
Gau M; Fonseca A; Ozsahin M; Fayette J; Poupart M; Roux PE; Schütz F; Zrounba P; Grégoire V
Oral Oncol; 2021 Dec; 123():105605. PubMed ID: 34800789
[TBL] [Abstract][Full Text] [Related]
37. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.
Ock CY; Keam B; Lim Y; Kim TM; Lee SH; Kwon SK; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
Head Neck; 2016 Feb; 38(2):277-84. PubMed ID: 26104823
[TBL] [Abstract][Full Text] [Related]
38. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer.
Lin J; Peng J; Qdaisat A; Li L; Chen G; Lu Z; Wu X; Gao Y; Zeng Z; Ding P; Pan Z
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2551-2560. PubMed ID: 27613188
[TBL] [Abstract][Full Text] [Related]
39. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
